메뉴 건너뛰기




Volumn 39, Issue 9, 2009, Pages 606-612

Selection of medical patients for prophylaxis of venous thromboembolism based on analysis of the benefit-hazard ratio

Author keywords

Benefit harm ratio; Low molecular weight heparin; Major bleeding; Thromboprophylaxis; Treatment guideline; Venous thromboembolism

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

EID: 65549154423     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01796.x     Document Type: Article
Times cited : (10)

References (12)
  • 1
    • 70349354760 scopus 로고    scopus 로고
    • The National Institute for Clinical Studies. [cited 2008 Sep]. URL
    • The National Institute for Clinical Studies. NICS Venous Thromboembolism Prevention Program: Project planning template (2005) [cited 2008 Sep]. URL : http://www.nhmrc.gov.au/nics/data/mediacache/21036001178771897078/ 008%20NICS%20VTE%20Prevention%20Program%20project%20plan%20template%20%5BPDF% 20276KB%5D.doc
    • (2005) NICS Venous Thromboembolism Prevention Program: Project planning template
  • 2
    • 4644288189 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism. Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW et al. Prevention of venous thromboembolism. Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 : 338S 400S.
    • (2004) Chest , vol.126
    • Geerts, W.H.1    Pineo, G.F.2    Heit, J.A.3    Bergqvist, D.4    Lassen, M.R.5    Colwell, C.W.6
  • 3
    • 4143085802 scopus 로고    scopus 로고
    • Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
    • PREVENT Medical Thromboprophylaxis Study Group.
    • Leizorovicz A, Cohen AT, Turpie AGG, Olsson C.-G, Vaitkus PT, Goldhaber SZ. PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004 110 : 874-9.
    • (2004) Circulation , vol.110 , pp. 874-879
    • Leizorovicz, A.1    Cohen, A.T.2    Turpie, A.G.G.3    Olsson C.-G4    Vaitkus, P.T.5    Goldhaber, S.Z.6
  • 4
    • 0033539025 scopus 로고    scopus 로고
    • Prophylaxis in medical patients with enoxaparin study group. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
    • Samama MM, Cohen AT, Darmon J-Y, Desjardins L, Eldor A, Janbon C et al. Prophylaxis in Medical Patients with Enoxaparin Study Group. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999 341 : 793 800.
    • (1999) N Engl J Med , vol.341 , pp. 793-800
    • Samama, M.M.1    Cohen, A.T.2    Darmon J-Y3    Desjardins, L.4    Eldor, A.5    Janbon, C.6
  • 5
    • 34247885965 scopus 로고    scopus 로고
    • Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalised medical patients: results from a cost-effectiveness analysis
    • Shorr AF, Jackson WL, Weiss BM, Moores LK. Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalised medical patients: results from a cost-effectiveness analysis. Blood Coagul Fibrinolysis 2007 18 : 309-16.
    • (2007) Blood Coagul Fibrinolysis , vol.18 , pp. 309-316
    • Shorr, A.F.1    Jackson, W.L.2    Weiss, B.M.3    Moores, L.K.4
  • 6
    • 4644221798 scopus 로고    scopus 로고
    • Cost effectiveness of thromboprophylaxis with a low molecular weight heparin versus unfractionated heparin in acutely ill medical patients
    • McGarry LJ, Thompson D, Weisntein MC, Goldhaber SZ. Cost effectiveness of thromboprophylaxis with a low molecular weight heparin versus unfractionated heparin in acutely ill medical patients. Am J Manag Care 2004 10 : 632 642.
    • (2004) Am J Manag Care , vol.10 , pp. 632-642
    • McGarry, L.J.1    Thompson, D.2    Weisntein, M.C.3    Goldhaber, S.Z.4
  • 7
    • 33750561899 scopus 로고    scopus 로고
    • Risk of venous thromboembolism in hospitalised medically ill patients
    • Edelsberg J, Hagiwara M, Taneja C, Oster G. Risk of venous thromboembolism in hospitalised medically ill patients. Am J Health-Syst Pharm 2006 63 (Suppl. 6 S16 21.
    • (2006) Am J Health-Syst Pharm , vol.63 , Issue.SUPPL. 6
    • Edelsberg, J.1    Hagiwara, M.2    Taneja, C.3    Oster, G.4
  • 8
    • 2342514219 scopus 로고    scopus 로고
    • Risk factors for venous thromboembolism in hospitalised patients with acute medical illness: analysis of the MEDENOX study
    • Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A et al. Risk factors for venous thromboembolism in hospitalised patients with acute medical illness: analysis of the MEDENOX study. Arch Intern Med 2004 164 : 963 968.
    • (2004) Arch Intern Med , vol.164 , pp. 963-968
    • Alikhan, R.1    Cohen, A.T.2    Combe, S.3    Samama, M.M.4    Desjardins, L.5    Eldor, A.6
  • 9
    • 34447628973 scopus 로고    scopus 로고
    • Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients
    • Wein L, Wein S, Haas S.-J, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients. Arch Intern Med 2007 167 : 1476 1486.
    • (2007) Arch Intern Med , vol.167 , pp. 1476-1486
    • Wein, L.1    Wein, S.2    Haas S.-J3    Shaw, J.4    Krum, H.5
  • 10
    • 33847315234 scopus 로고    scopus 로고
    • Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients
    • Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007 146 : 278-88.
    • (2007) Ann Intern Med , vol.146 , pp. 278-288
    • Dentali, F.1    Douketis, J.D.2    Gianni, M.3    Lim, W.4    Crowther, M.A.5
  • 12
    • 34248383764 scopus 로고    scopus 로고
    • Best Practice Guidelines for Australia and New Zealand The Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism. Health Education & Management Innovations Pty Ltd
    • The Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism. Prevention of Venous Thromboembolism 4th edition. Best Practice Guidelines for Australia and New Zealand, Health Education & Management Innovations Pty Ltd, 2007.
    • (2007) Prevention of Venous Thromboembolism 4th edition


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.